Cover Image
市場調查報告書

分子組織學、細胞學市場:HPV、原位雜合反應、CTS、流式細胞技術

The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)

出版商 Kalorama Information 商品編碼 349952
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
分子組織學、細胞學市場:HPV、原位雜合反應、CTS、流式細胞技術 The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)
出版日期: 2016年01月01日 內容資訊: 英文 110 Pages
簡介

HPV、原位雜合反應、CTS、流式細胞技術等技術發展,細胞檢驗、組織檢驗市場顯示兩位數成長、成為富有魅力的市場。

本報告提供分子組織學、細胞學市場相關調查分析,市場概要,主要企業簡介等相關整體分析彙整。

第1章 摘要整理

  • 調查的範圍
  • 最新技術
  • 市場規模與成長

第2章 市場分析

  • 各地區市場
  • 樣品作成
  • 原位雜合反應
  • 螢光原位雜交計數系統(FISH)
  • HPV檢驗
  • 分子HPV和Pap試驗
  • 血中循環腫瘤細胞
  • Veridex
  • Qiagen,Roche
  • CTC市場
  • 流式細胞技術
  • 藥理診斷組織學

第3章 企業簡介

  • Abbott Diagnostics
  • Advanced Cell Diagnostics (ACD)
  • Amoy Diagnostics Co. Ltd.
  • Applied Spectral Imaging Inc. (ASI)
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson and Company (BD) Franklin Lakes, NJ
  • BioView Ltd.
  • Circulomics Inc.
  • Covaris Inc.
  • Cymogen Dx, LLC
  • Dako A/S
  • Definiens
  • DxTerity Diagnostics Inc.
  • General Electric - GE Healthcare
  • Hologic, Inc.
  • HTG Molecular Diagnostics
  • Janssen Diagnostics
  • Kapa Biosystems Inc.
  • Leica Biosystems
  • PreTect AS (舊Norchip)
  • QIAGEN N.V.
  • Roche Diagnostics
  • Sony Biotechnology ( iCyt )
  • Sysmex Corporation Kobe, Japan
  • Ventana Medical Systems Inc.

另紙

目錄
Product Code: KLI5816896

Double-digit revenue growth has attracted companies investors into the market for the testing of cells and tissues, according to Kalorama Information's report. Molecular approaches have improved testing for genetic and protein markers in tissues and cells respectively. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing and mass spectrometry.

The result so far has been gene patterns that help distinguish cell and tumor attributes that demonstrate the presence of disease as well as risk for disease progression and sensitivity to specific therapeutics. A growing population of cancer patients has increased the number of histology analyses performed.

Further, developments in cytology and cervical cancer diagnosis fuel a continuous stream of innovation. For at least the past twenty years molecular analysis of tissue biopsies involves some form of in situ hybridization. Bit by bit, PCR, other amplification technologies and sequencing techniques are making their way into routine tissue analysis, especially for difficult to manage cases.

This report focuses on molecular histology and cytology approaches to testing, and the market for these technologies. The tests are used primarily to test biopsied tissue for cancer; cervical fluid for sexually transmitted diseases and HPV; and circulating tumor cells. Markets covered in this report include:

  • In Situ Hybridization
  • HPV Testing
  • Circulating Tumor Cells
  • Tissue Microarrays
  • Flow Cytometry

The molecular histology and cytology market is highly competitive and scores of companies participate. Companies profiled in this report include:

  • Abbott Diagnostics
  • Advanced Cell Diagnostics (ACD)
  • Amoy Diagnostics Co. Ltd.
  • Applied Spectral Imaging Inc. (ASI)
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson and Company (BD) Franklin Lakes, NJ
  • BioView Ltd.
  • Circulomics Inc.
  • Covaris Inc.
  • Cymogen Dx, LLC
  • Dako A/S
  • Definiens
  • DxTerity Diagnostics Inc.
  • General Electric - GE Healthcare
  • Hologic, Inc.
  • HTG Molecular Diagnostics
  • Janssen Diagnostics
  • Kapa Biosystems Inc.
  • Leica Biosystems
  • PreTect AS (formerly Norchip)
  • QIAGEN N.V.
  • Roche Diagnostics
  • Sony Biotechnology ( iCyt )
  • Sysmex Corporation Kobe, Japan
  • Ventana Medical Systems Inc.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Segments Covered
  • Advanced Technologies
  • Size and Growth in the Market

CHAPTER TWO: MARKET ANALYSIS

  • Market by Geographic Region
  • Sample Preparation
  • In Situ Hybridization
  • Fluorescence in situ Hybridization (FISH)
  • HPV Testing
  • Molecular HPV and Pap Smear
  • Circulating Tumor Cells
  • Veridex
  • Qiagen, Roche
  • CTC Market
  • Flow Cytometry
  • Pharmacodiagnostic Histology

CHAPTER THREE: COMPANY PROFILES

  • Abbott Diagnostics
  • Advanced Cell Diagnostics (ACD)
  • Amoy Diagnostics Co. Ltd.
  • Applied Spectral Imaging Inc. (ASI)
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson and Company (BD) Franklin Lakes, NJ
  • BioView Ltd.
  • Circulomics Inc.
  • Covaris Inc.
  • Cymogen Dx, LLC
  • Dako A/S
  • Definiens
  • DxTerity Diagnostics Inc.
  • General Electric - GE Healthcare
  • Hologic, Inc.
  • HTG Molecular Diagnostics
  • Janssen Diagnostics
  • Kapa Biosystems Inc.
  • Leica Biosystems
  • PreTect AS (formerly Norchip)
  • QIAGEN N.V.
  • Roche Diagnostics
  • Sony Biotechnology ( iCyt )
  • Sysmex Corporation Kobe, Japan
  • Ventana Medical Systems Inc.

TABLE OF EXHIBITS

  • Figure 1-1: Market Trend by Type, 2015 and 2020 (in situ hybridization, HPV, Tissue Microarrays, CTC, Flow Cytometry)
  • Table 2-1: Worldwide Molecular Histology/Cytology Sales, by Type, 2015 and 2020 (in situ hybridization, HPV, Tissue Microarrays, CTC, Flow Cytometry)
  • Figure 2-1: Molecular Histology and Cytology Sales, 2015 and 2020
  • Figure 2-2: Worldwide Molecular Histology/Cytology Sales, by Region (US, EU, Asia, ROW)
  • Table 2-2: Selected Molecular Histology Innovations, 2015
  • Table 2-3: Selected FFPE DNA/RNA Sample Preparation Innovations
  • Table 2-4: Selected Companies with in situ hybridization tests on the Market or In Development for Cancer Diagnostics (Company, Comment, Market Status)
  • Figure 2-3: Pap and Molecular HPV Market Trend Compared
  • Table 2-5: Selected HPV Test Innovations
  • Table 2-6: Selected Innovations in CTC Technology
  • Table 2-7: Selected Companies Marketing Flow Cytometry Platforms or Consumables
  • Table 2-8: Major Pharmacodiagnostic Markers
  • Table 2-9: Selected Pharmacodiagnostic Histology Tests 33
Back to Top